| Abbott Laboratories |
ABT |
🇺🇸 |
New York Stock Exchange |
$168.7bn |
Large Cap America DividendMax America |
| Abbvie Inc |
ABBV |
🇺🇸 |
New York Stock Exchange |
$464.3bn |
DividendMax America Large Cap America |
| Abcam |
ABC |
🇬🇧 |
London Stock Exchange |
£2.8bn |
|
| Abiomed Inc. |
ABMD |
🇺🇸 |
NASDAQ |
$17.2bn |
DividendMax America |
| Adma Biologics Inc |
ADMA |
🇺🇸 |
NASDAQ |
$2.2bn |
|
| Advanced Medical Solutions Group |
AMS |
🇬🇧 |
London Stock Exchange |
£624mn |
|
| Aflac Inc. |
AFL |
🇺🇸 |
New York Stock Exchange |
$55.9bn |
DividendMax America |
| Alcon Inc. |
ALC |
🇨🇠|
SIX Swiss Exchange |
Fr.26.4bn |
STOXX600 |
| Align Technology, Inc. |
ALGN |
🇺🇸 |
NASDAQ |
$10.3bn |
DividendMax America |
| Alliance Pharma plc |
APH |
🇬🇧 |
London Stock Exchange |
£350mn |
|
| AMGEN Inc. |
AMGN |
🇺🇸 |
NASDAQ |
$217.9bn |
Large Cap America NASDAQ 100 DividendMax America |
| Animalcare Group Plc |
ANCR |
🇬🇧 |
London Stock Exchange |
£231mn |
|
| Argen X SE |
ARGX |
🇧🇪 |
Euronext Brussels |
€51.0bn |
STOXX600 Euronext 100 |
| Arix Bioscience Plc |
ARIX |
🇬🇧 |
London Stock Exchange |
£184mn |
|
| Aspira Women's Health Inc |
AWHL |
🇺🇸 |
OTC Markets Group |
$4mn |
|
| Astellas Pharma Inc. |
4503 |
🇯🇵 |
Tokyo Stock Exchange |
Â¥4062.7bn |
|
| Astrazeneca plc |
AZN |
🇬🇧 |
London Stock Exchange |
£184.1bn |
FTSE 100 FTSE 350 FTSE Eurotop 100 CBOE 100 CBOE 350 OMX Stockholm 30 STOXX600 |
| Avacta Group Plc |
AVCT |
🇬🇧 |
London Stock Exchange |
£339mn |
|
| Basilea Pharmaceutica AG |
BSLN |
🇨🇠|
SIX Swiss Exchange |
Fr.898mn |
|
| Bavarian Nordic A/S |
BAVA |
🇩🇰 |
Copenhagen Stock Exchange |
kr.17.2bn |
|
| Bayer AG |
BAYN |
🇩🇪 |
Frankfurt Stock Exchange |
€44.6bn |
Euro Stoxx 50 DAX 40 FTSE Eurotop 100 TSIC Euro30 STOXX600 |
| BB Biotech AG |
BION |
🇨🇠|
SIX Swiss Exchange |
Fr.2.8bn |
STOXX600 |
| Becton Dickinson & Co. |
BDX |
🇺🇸 |
New York Stock Exchange |
$48.7bn |
DividendMax America |
| Beximco Pharmaceuticals Plc - GDR - Reg S |
BXP |
🇬🇧 |
London Stock Exchange |
£49mn |
|
| Biogen Inc |
BIIB |
🇺🇸 |
NASDAQ |
$32.5bn |
NASDAQ 100 DividendMax America Large Cap America |
| Biomarin Pharmaceutical Inc. |
BMRN |
🇺🇸 |
NASDAQ |
$11.1bn |
|
| Biomerieux |
BIM |
🇫🇷 |
Euronext Paris |
€9.1bn |
STOXX600 |
| Bio-Rad Laboratories Inc. - Class A Shares |
BIO |
🇺🇸 |
New York Stock Exchange |
$8.0bn |
DividendMax America |
| Biora Therapeutics Inc |
PROG |
🇺🇸 |
NASDAQ |
$3mn |
|
| Biosynex |
ALBIO |
🇫🇷 |
Euronext Paris |
€10mn |
|
| Bio-Techne Corp |
TECH |
🇺🇸 |
NASDAQ |
$11.4bn |
DividendMax America |
| Bluebird bio Inc |
BLUE |
🇺🇸 |
NASDAQ |
$49mn |
|
| Boiron |
BOI |
🇫🇷 |
Euronext Paris |
€347mn |
|
| Boston Scientific Corp. |
BSX |
🇺🇸 |
New York Stock Exchange |
$61.7bn |
DividendMax America |
| Bristol-Myers Squibb Co. |
BMY |
🇺🇸 |
New York Stock Exchange |
$124.9bn |
Large Cap America DividendMax America |
| Canopy Growth Corporation |
WEED |
🇨🇦 |
Toronto Stock Exchange |
C$533mn |
|
| Carbios |
ALCRB |
🇫🇷 |
Euronext Paris |
€92mn |
|
| Carl Zeiss Meditec A G |
AFX |
🇩🇪 |
Frankfurt Stock Exchange |
€2.7bn |
STOXX600 |
| Catalent Inc. |
CTLT |
🇺🇸 |
New York Stock Exchange |
$11.5bn |
DividendMax America |
| Cel AI Plc |
CLAI |
🇬🇧 |
Nex Exchange |
£8mn |
|
| Celanese Corp - Ordinary Shares - Series A |
CE |
🇺🇸 |
New York Stock Exchange |
$4.9bn |
DividendMax America |
| Cencora Inc. |
COR |
🇺🇸 |
New York Stock Exchange |
$59.0bn |
DividendMax America |
| Charles River Laboratories International Inc. |
CRL |
🇺🇸 |
New York Stock Exchange |
$13.9bn |
DividendMax America |
| Charlottes Web Holdings Inc |
CWEB |
🇨🇦 |
Toronto Stock Exchange |
C$103mn |
|
| Compugen Ltd |
CGEN |
🇮🇱 |
Tel Aviv Stock Exchange |
₪682mn |
|
| CompuGroup Medical SE & Co. KgaA |
COP |
🇩🇪 |
Frankfurt Stock Exchange |
€1.2bn |
|
| Conformis Inc. |
CFMS |
🇺🇸 |
NASDAQ |
$18mn |
|
| ConvaTec Group Plc |
CTEC |
🇬🇧 |
London Stock Exchange |
£4.2bn |
FTSE 350 STOXX600 FTSE 100 |
| Creative Medical Technology Holdings Inc |
CELZ |
🇺🇸 |
NASDAQ |
$6mn |
|
| CRISPR Therapeutics AG |
CRSP |
🇺🇸 |
NASDAQ |
$5.4bn |
|
| CSL Ltd. |
CSL |
🇦🇺 |
Australian Stock Exchange |
AU$84.1bn |
|
| CVR Partners LP - Unit |
UAN |
🇺🇸 |
New York Stock Exchange |
$1.3bn |
|
| Daiichi Sankyo Co., Ltd. |
4568 |
🇯🇵 |
Tokyo Stock Exchange |
Â¥5046.6bn |
|
| Dechra Pharmaceuticals plc |
DPH |
🇬🇧 |
London Stock Exchange |
£4.4bn |
FTSE 350 CBOE 250 CBOE 350 STOXX600 FTSE 250 |
| Dermapharm Holding SE |
DMP |
🇩🇪 |
Frankfurt Stock Exchange |
€1.9bn |
|
| Destiny Pharma Plc |
DEST |
🇬🇧 |
London Stock Exchange |
£3mn |
|
| Dexcom Inc |
DXCM |
🇺🇸 |
NASDAQ |
$32.2bn |
DividendMax America |
| Diasorin S.p.A. |
DIA |
🇮🇹 |
Italian Stock Exchange |
€1.8bn |
STOXX600 |
| Dr. Reddy's Laboratories Ltd. - ADR |
RDY |
🇺🇸 |
New York Stock Exchange |
$10.2bn |
|
| DSM-Firmenich AG |
DSFIR |
🇳🇱 |
Euronext Amsterdam |
€24.4bn |
Euronext 100 |
| Eco Animal Health Group Plc |
EAH |
🇬🇧 |
London Stock Exchange |
£66mn |
|
| Elevation Oncology Inc |
ELEV |
🇺🇸 |
NASDAQ |
$22mn |
|
| Ergomed Plc |
ERGO |
🇬🇧 |
London Stock Exchange |
£701mn |
|
| Eurofins Scientific S.E. |
ERF |
🇫🇷 |
Euronext Paris |
€13.2bn |
STOXX600 |
| Evotec SE |
EVT |
🇩🇪 |
Frankfurt Stock Exchange |
€548mn |
STOXX600 |
| Exact Sciences Corp. |
EXAS |
🇺🇸 |
NASDAQ |
$20.0bn |
|
| Futura Medical |
FUM |
🇬🇧 |
London Stock Exchange |
£3mn |
|
| Genedrive Plc |
GDR |
🇬🇧 |
London Stock Exchange |
£19mn |
|
| Genmab |
GMAB |
🇩🇰 |
Copenhagen Stock Exchange |
kr.144.3bn |
STOXX600 |
| Genus plc |
GNS |
🇬🇧 |
London Stock Exchange |
£1.4bn |
FTSE 250 FTSE 350 CBOE 250 CBOE 350 |
| Gerresheimer AG |
GXI |
🇩🇪 |
Frankfurt Stock Exchange |
€956mn |
STOXX600 |
| Getinge AB - Class B Shares |
GETI B |
🇸🇪 |
Stockholm Stock Exchange |
kr62.8bn |
STOXX600 |
| Gilead Sciences, Inc. |
GILD |
🇺🇸 |
NASDAQ |
$179.5bn |
Large Cap America NASDAQ 100 DividendMax America |
| Grifols SA |
GRF |
🇪🇸 |
Barcelona Stock Exchange |
€8.3bn |
IBEX 35 STOXX600 |
| GSK Plc |
GSK |
🇬🇧 |
London Stock Exchange |
£72.0bn |
FTSE 100 FTSE 350 FTSE Eurotop 100 STOXX600 CBOE 100 CBOE 350 |
| GSK Plc - ADR |
GSK |
🇺🇸 |
New York Stock Exchange |
$95.1bn |
|
| Hikma Pharmaceuticals Plc |
HIK |
🇬🇧 |
London Stock Exchange |
£3.3bn |
FTSE 350 CBOE 100 CBOE 350 STOXX600 FTSE 250 |
| H. Lundbeck AS |
LUN |
🇩🇰 |
Copenhagen Stock Exchange |
kr.34.4bn |
STOXX600 |
| Hologic, Inc. |
HOLX |
🇺🇸 |
NASDAQ |
$17.0bn |
DividendMax America |
| hVIVO Plc. |
HVO |
🇬🇧 |
London Stock Exchange |
£41mn |
|
| Icon Plc |
ICLR |
🇺🇸 |
NASDAQ |
$13.1bn |
|
| Illumina Inc |
ILMN |
🇺🇸 |
NASDAQ |
$41.2bn |
NASDAQ 100 DividendMax America |
| Immunovant Inc |
IMVT |
🇺🇸 |
NASDAQ |
$6.9bn |
|
| Immunovia AB |
IMMNOV |
🇸🇪 |
Stockholm Stock Exchange |
kr57mn |
|
| Incyte Corp. |
INCY |
🇺🇸 |
NASDAQ |
$23.4bn |
DividendMax America |
| Indivior Plc |
INDV |
🇺🇸 |
NASDAQ |
$4.1bn |
CBOE 250 CBOE 350 |
| Integrated Diagnostics Holdings Plc |
IDHC |
🇬🇧 |
London Stock Exchange |
£241mn |
|
| Intellia Therapeutics Inc |
NTLA |
🇺🇸 |
NASDAQ |
$1.7bn |
|
| Intervacc AB |
IVACC |
🇸🇪 |
Stockholm Stock Exchange |
kr351mn |
|
| Ipsen |
IPN |
🇫🇷 |
Euronext Paris |
€11.7bn |
STOXX600 |
| Ixico Plc |
IXI |
🇬🇧 |
London Stock Exchange |
£16mn |
|
| Johnson & Johnson |
JNJ |
🇺🇸 |
New York Stock Exchange |
$617.0bn |
Dow Jones 30 Large Cap America BBC Global 30 DividendMax America |
| Kanabo Group Plc |
KNB |
🇬🇧 |
London Stock Exchange |
£1mn |
|
| Laboratorios Farmaceuticos Rovi S.A. |
ROVI |
🇪🇸 |
Madrid Stock Exchange |
€2.9bn |
|
| Laboratory Corp. Of America Holdings |
LH |
🇺🇸 |
New York Stock Exchange |
$18.0bn |
DividendMax America |
| Lakefront Biotherapeutics NV |
LKFT |
🇳🇱 |
Euronext Amsterdam |
€1.7bn |
STOXX600 AEX 25 |
| Lifevantage Corporation |
LFVN |
🇺🇸 |
NASDAQ |
$76mn |
DividendMax America |
| Lilly(Eli) & Co |
LLY |
🇺🇸 |
New York Stock Exchange |
$1075.8bn |
Large Cap America DividendMax America |
| Lonza Group AG |
LONN |
🇨🇠|
SIX Swiss Exchange |
Fr.39.7bn |
STOXX600 |
| Mckesson Corporation |
MCK |
🇺🇸 |
New York Stock Exchange |
$105.2bn |
DividendMax America |
| Medtronic Plc |
MDT |
🇺🇸 |
New York Stock Exchange |
$110.5bn |
Large Cap America DividendMax America |
| Merck & Co Inc |
MRK |
🇺🇸 |
New York Stock Exchange |
$356.0bn |
Dow Jones 30 Large Cap America DividendMax America |
| Merck & Co Inc - Canadian Depository Receipt (CAD Hedged) |
MRK |
🇨🇦 |
Toronto Stock Exchange |
C$29mn |
|
| Merck KGAA |
MRK |
🇩🇪 |
Frankfurt Stock Exchange |
€17.3bn |
DAX 40 STOXX600 |
| MGC Pharmaceuticals Ltd |
MXC |
🇦🇺 |
Australian Stock Exchange |
AU$3mn |
|
| Moderna Inc |
MRNA |
🇺🇸 |
NASDAQ |
$75.9bn |
DividendMax America |
| Morphosys AG |
MOR |
🇩🇪 |
Frankfurt Stock Exchange |
€2.6bn |
STOXX600 |
| Nektar Therapeutics |
NKTR |
🇺🇸 |
NASDAQ |
$1.5bn |
|
| NIOX Group Plc |
NIOX |
🇬🇧 |
London Stock Exchange |
£281mn |
|
| Novartis AG - Ordinary Shares (Registered) |
NOVN |
🇨🇠|
SIX Swiss Exchange |
Fr.236.7bn |
FTSE Eurotop 100 BBC Global 30 STOXX600 |
| Novavax, Inc. |
NVAX |
🇺🇸 |
NASDAQ |
$1.7bn |
|
| NovoCure Ltd |
NVCR |
🇺🇸 |
NASDAQ |
$1.7bn |
|
| Novonesis AS - Class B Shares |
NSIS B |
🇩🇰 |
Copenhagen Stock Exchange |
kr.171.2bn |
STOXX600 OMX Copenhagen 20 |
| Novo Nordisk - ADR |
NVO |
🇺🇸 |
New York Stock Exchange |
$126.5bn |
|
| Novo Nordisk - Class B Shares |
NOVO B |
🇩🇰 |
Copenhagen Stock Exchange |
kr.847.5bn |
OMX Copenhagen 20 STOXX600 |
| OptiBiotix Health plc |
OPTI |
🇬🇧 |
London Stock Exchange |
£6mn |
|
| Organon & Co. |
OGN |
🇺🇸 |
New York Stock Exchange |
$3.6bn |
DividendMax America |
| Oxford BioDynamics Plc |
OBD |
🇬🇧 |
London Stock Exchange |
£16mn |
|
| Oxford Biomedica |
OXB |
🇬🇧 |
London Stock Exchange |
£659mn |
FTSE 250 FTSE 350 |
| Oxford Nanopore Technologies Plc |
ONT |
🇬🇧 |
London Stock Exchange |
£2.2bn |
FTSE 250 FTSE 350 |
| Patterson Companies Inc. |
PDCO |
🇺🇸 |
NASDAQ |
$2.8bn |
|
| Perrigo Company plc |
PRGO |
🇺🇸 |
New York Stock Exchange |
$2.0bn |
DividendMax America |
| Pfizer Inc. |
PFE |
🇺🇸 |
New York Stock Exchange |
$158.5bn |
Dow Jones 30 Large Cap America DividendMax America |
| Pharming Group N.V. |
PHARM |
🇳🇱 |
Euronext Amsterdam |
€616mn |
|
| PolarityTE Inc |
PTEIQ |
🇺🇸 |
OTC Markets Group |
$2mn |
|
| Provexis Plc |
PXS |
🇬🇧 |
London Stock Exchange |
£23mn |
|
| Qiagen NV |
QGEN |
🇺🇸 |
New York Stock Exchange |
$9.2bn |
STOXX600 DAX 40 |
| Recordati SpA |
REC |
🇮🇹 |
Italian Stock Exchange |
€11.0bn |
STOXX600 |
| Regeneron Pharmaceuticals, Inc. |
REGN |
🇺🇸 |
NASDAQ |
$74.4bn |
DividendMax America |
| Roche Holding AG |
ROG |
🇨🇠|
SIX Swiss Exchange |
Fr.226.4bn |
FTSE Eurotop 100 STOXX600 |
| Royalty Pharma plc - Class A Shares |
RPRX |
🇺🇸 |
NASDAQ |
$25.5bn |
|
| Sanofi |
SAN |
🇫🇷 |
Euronext Paris |
€85.5bn |
Euro Stoxx 50 CAC 40 FTSE Eurotop 100 Euronext 100 TSIC Euro30 STOXX600 |
| Sareum Holdings Plc |
SAR |
🇬🇧 |
London Stock Exchange |
£42mn |
|
| Sartorius AG |
SRT |
🇩🇪 |
Frankfurt Stock Exchange |
€7.0bn |
|
| Sartorius AG - Preference Share |
SRT3 |
🇩🇪 |
Frankfurt Stock Exchange |
€9.4bn |
STOXX600 DAX 40 |
| Sartorius Stedim Biotech S.A. |
DIM |
🇫🇷 |
Euronext Paris |
€20.3bn |
STOXX600 |
| Siemens Healthineers AG |
SHL |
🇩🇪 |
Frankfurt Stock Exchange |
€42.1bn |
STOXX600 DAX 40 |
| Sonova Holding AG |
SOON |
🇨🇠|
SIX Swiss Exchange |
Fr.14.8bn |
STOXX600 |
| Steris Plc |
STE |
🇺🇸 |
New York Stock Exchange |
$20.3bn |
DividendMax America |
| Sundial Growers Inc |
SNDL |
🇺🇸 |
NASDAQ |
$319mn |
|
| Swedencare AB |
SECARE |
🇸🇪 |
Stockholm Stock Exchange |
kr3.4bn |
|
| Swedish Orphan Biovitrum AB |
SOBI |
🇸🇪 |
Stockholm Stock Exchange |
kr155.3bn |
STOXX600 |
| Synairgen |
SNG |
🇬🇧 |
London Stock Exchange |
£2mn |
|
| Syncona Limited |
SYNC |
🇬🇧 |
London Stock Exchange |
£742mn |
FTSE 250 FTSE 350 |
| Takeda Pharmaceutical Co |
4502 |
🇯🇵 |
Tokyo Stock Exchange |
Â¥9040.9bn |
|
| Takeda Pharmaceutical Co - ADR |
TAK |
🇺🇸 |
New York Stock Exchange |
$57.2bn |
|
| Teleflex Incorporated |
TFX |
🇺🇸 |
New York Stock Exchange |
$5.3bn |
DividendMax America |
| Teva- Pharmaceutical Industries Ltd. - ADR |
TEVA |
🇺🇸 |
New York Stock Exchange |
$43.2bn |
|
| Tilray Brands Inc |
TLRY |
🇺🇸 |
NASDAQ |
$533mn |
|
| Tissue Regenix Group Plc |
TRX1 |
🇬🇧 |
London Stock Exchange |
£5mn |
|
| UCB SA |
UCB |
🇧🇪 |
Euronext Brussels |
€39.7bn |
BEL 20 Euronext 100 STOXX600 |
| Uniphar Plc |
UPR |
🇮🇪 |
Irish Stock Exchange |
€1.0bn |
|
| Venture Life Group Plc |
VLG |
🇬🇧 |
London Stock Exchange |
£82mn |
|
| Vertex Pharmaceuticals, Inc. |
VRTX |
🇺🇸 |
NASDAQ |
$128.1bn |
NASDAQ 100 DividendMax America |
| Viatris Inc |
VTRS |
🇺🇸 |
NASDAQ |
$20.2bn |
DividendMax America |
| West Pharmaceutical Services, Inc. |
WST |
🇺🇸 |
New York Stock Exchange |
$25.7bn |
DividendMax America |
| Zealand Pharma A/S. |
ZEAL |
🇩🇰 |
Copenhagen Stock Exchange |
kr.18.2bn |
|
